Position in LH
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,207,852
+$175,474 QoQ
Shares Held
8,275
+2.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Private Advisor Group, LLC holds $25,798,086 across 14 Diagnostics & Research names. LH ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
16,614 | $8,166,279 | |
| 2 | DHR |
Danaher Corp /De/
|
33,228 | $6,300,028 | |
| 3 | WAT |
Waters Corp /De/
|
7,602 | $2,263,875 | |
| 4 | LH |
Labcorp Holdings Inc.
This page
|
8,275 | $2,207,852 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,506 | $1,408,096 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
2,342 | $1,124,604 | |
| 7 | DGX |
Quest Diagnostics Inc
|
5,415 | $1,061,231 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
6,146 | $1,048,138 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,207,852 | 8,275 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,032,378 | 8,101 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,253,708 | 7,851 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,087,217 | 7,951 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,915,682 | 8,231 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,122,356 | 9,255 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,879,466 | 8,410 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,103,024 | 5,420 | Shares | Sole | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||